# Sentinel lympH Node Biopsy With Indocyanine Green in Breast Cancer After NEoadjuvant Chemotherapy (SHINE)

> **NCT06085274** · NA · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 100 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** ICG guided sentinel lymph node biopsy

## Key facts

- **NCT ID:** NCT06085274
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-03
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06085274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06085274, "Sentinel lympH Node Biopsy With Indocyanine Green in Breast Cancer After NEoadjuvant Chemotherapy (SHINE)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06085274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*